John H. Merrett

1.5k total citations · 1 hit paper
10 papers, 1.2k citations indexed

About

John H. Merrett is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, John H. Merrett has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in John H. Merrett's work include HIV/AIDS drug development and treatment (4 papers), Biochemical and Molecular Research (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). John H. Merrett is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Biochemical and Molecular Research (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). John H. Merrett collaborates with scholars based in United Kingdom, United States and Switzerland. John H. Merrett's co-authors include Joseph A. Martin, K. E. B. PARKES, I. B. R. Duncan, Gareth J. Thomas, S. Galpin, Robert Lambert, Derek Kinchington, John Kay, Peter J. Machin and John Mills and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

John H. Merrett

10 papers receiving 1.1k citations

Hit Papers

Rational Design of Peptide-Based HIV Proteinase Inhibitors 1990 2026 2002 2014 1990 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John H. Merrett United Kingdom 8 684 499 429 293 252 10 1.2k
S. Galpin United Kingdom 14 828 1.2× 707 1.4× 365 0.9× 211 0.7× 272 1.1× 23 1.2k
Derek Kinchington United Kingdom 17 954 1.4× 726 1.5× 589 1.4× 325 1.1× 307 1.2× 41 1.5k
Piet Wigerinck Belgium 19 1.1k 1.6× 768 1.5× 438 1.0× 439 1.5× 421 1.7× 44 1.8k
K. E. B. PARKES United Kingdom 15 640 0.9× 513 1.0× 632 1.5× 400 1.4× 204 0.8× 32 1.4k
Alison J. Ritchie United Kingdom 9 597 0.9× 531 1.1× 416 1.0× 232 0.8× 167 0.7× 9 1.0k
Pin‐Fang Lin United States 22 753 1.1× 740 1.5× 437 1.0× 160 0.5× 146 0.6× 30 1.4k
Sally Redshaw United Kingdom 11 715 1.0× 594 1.2× 503 1.2× 376 1.3× 104 0.4× 26 1.3k
Johnson Agniswamy United States 24 745 1.1× 601 1.2× 446 1.0× 304 1.0× 180 0.7× 55 1.3k
William E. Kohlbrenner United States 19 924 1.4× 695 1.4× 774 1.8× 521 1.8× 353 1.4× 34 1.9k
Anne V. Broadhurst United Kingdom 6 591 0.9× 514 1.0× 302 0.7× 216 0.7× 102 0.4× 8 855

Countries citing papers authored by John H. Merrett

Since Specialization
Citations

This map shows the geographic impact of John H. Merrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Merrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Merrett more than expected).

Fields of papers citing papers by John H. Merrett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Merrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Merrett. The network helps show where John H. Merrett may publish in the future.

Co-authorship network of co-authors of John H. Merrett

This figure shows the co-authorship network connecting the top 25 collaborators of John H. Merrett. A scholar is included among the top collaborators of John H. Merrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John H. Merrett. John H. Merrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Klumpp, Klaus, Vincent Lévêque, Sophie Le Pogam, et al.. (2005). The Novel Nucleoside Analog R1479 (4′-Azidocytidine) Is a Potent Inhibitor of NS5B-dependent RNA Synthesis and Hepatitis C Virus Replication in Cell Culture. Journal of Biological Chemistry. 281(7). 3793–3799. 166 indexed citations
2.
PARKES, K. E. B., Philipp Ermert, Jane Ives, et al.. (2003). Use of a Pharmacophore Model To Discover a New Class of Influenza Endonuclease Inhibitors. Journal of Medicinal Chemistry. 46(7). 1153–1164. 125 indexed citations
3.
Martin, Joseph A., Robert Lambert, John H. Merrett, et al.. (2001). Nucleoside Analogues as Highly Potent and Selective Inhibitors of Herpes Simplex Virus Thymidine Kinase. Bioorganic & Medicinal Chemistry Letters. 11(13). 1655–1658. 11 indexed citations
4.
Abraham, Raymond J., et al.. (2000). Conformational analysis. Part 34. An NMR investigation of the conformational equilibrium and intramolecular hydrogen bonding in nipecotic acid derivatives. Journal of the Chemical Society Perkin Transactions 2. 2382–2392. 12 indexed citations
5.
PARKES, K. E. B., Peter H. Crackett, Richard A. Hopkins, et al.. (1994). ChemInform Abstract: Studies Toward the Large‐Scale Synthesis of the HIV Proteinase Inhibitor Ro 31‐8959.. ChemInform. 25(51). 3 indexed citations
7.
Manchand, Percy S., Joseph A. Martin, Christopher H. Hill, et al.. (1990). Synthesis and antiviral activity of metabolites of rimantadine. Journal of Medicinal Chemistry. 33(7). 1992–1995. 33 indexed citations
8.
Duncan, I. B. R., et al.. (1990). Synthesis and antiviral activity of monofluoro and difluoro analogs of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1). Journal of Medicinal Chemistry. 33(8). 2137–2145. 63 indexed citations
9.
Roberts, Noel A., Joseph A. Martin, Derek Kinchington, et al.. (1990). Rational Design of Peptide-Based HIV Proteinase Inhibitors. Science. 248(4953). 358–361. 726 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026